T1D

Metabolic·MeSH: Diabetes Mellitus, Type 1

17 drugs in development·11 companies·4 clinical trials

Drug Pipeline by Phase

Approved(3)

Phase 3(2)

Drug	Company
cadisegliatin	vTv Therapeutics Inc. (VTVT)
cadisegliatin 800 mg qd	vTv Therapeutics Inc. (VTVT)

Phase 1(2)

Drug	Company
nnc0497-0040	Novo Nordisk A/S (NVO)
up421	Sana Biotechnology, Inc. (SANA)

Preclinical(7)

Drug	Company
adi-100	Aditxt, Inc. (ADTX)
bihormonal ilet	Beta Bionics Inc. (BBNX)
ilt1	Lineage Cell Therapeutics, Inc. (LCTX)
patch pump	Beta Bionics Inc. (BBNX)
sc451	Sana Biotechnology, Inc. (SANA)
sig-002	Sigilon Therapeutics, Inc. (SGTX)
vicapsyn	Vicapsys Life Sciences, Inc. (VICP)

BLA Filed(2)

Drug	Company
prv-031	PROVENTION BIO, INC. (PBI)
teplizumab	PROVENTION BIO, INC. (PBI)

Phase 1/Phase 2(1)

Drug	Company
CTX211	CRISPR Therapeutics AG (CRSP)

BioSniper tracks 17 drugs in development for T1D across 11 companies.

There are 4 clinical trials targeting T1D tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.